Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 276.3M | 279.5M | 275.9M | 270.0M |
Cost of revenue | 60.7M | 58.8M | 55.6M | 55.5M |
Gross profit | 215.6M | 220.7M | 220.4M | 214.5M |
Operating expense | ||||
Research & development | 72.3M | 68.9M | 67.9M | 65.4M |
Selling general and admin | 137.0M | 133.9M | 129.1M | 128.8M |
Other operating expenses | — | — | — | — |
Operating income | 6.3M | 17.9M | 23.4M | 20.3M |
Non operating interest income | ||||
Income | 6.7M | 21.3M | — | 4.7M |
Expense | 2.7M | — | 6.1M | — |
Other income expense | 2.8M | — | — | — |
Pretax income | 13.1M | 21.0M | 17.3M | 25.0M |
Tax provision | 5.0M | -173.0M | 4.4M | 4.5M |
Net income | 8.2M | 194.0M | 12.9M | 20.5M |
Basic EPS | 0.0 | — | 0.1 | 0.1 |
Diluted EPS | 0.0 | — | 0.1 | 0.1 |
Basic average shares | 144.4M | — | 143.5M | 144.1M |
Diluted average shares | 149.6M | — | 149.1M | 146.5M |
EBITDA | 22.7M | 35.7M | 29.3M | 25.6M |
Net income from continuing op. | 8.2M | 194.0M | 12.9M | 20.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | 451K | 21.6M | 985K | 1.8M |